RemitDATA enters distribution agreement with SYNNEX

RemitDATA Inc., an industry expert in reimbursement and utilization data and analysis solutions in the outpatient healthcare market, announced today a new distribution agreement with SYNNEX Corporation (NYSE: SNX), a leading business process services company.

“There are three qualities that attracted us to SYNNEX”

The distribution agreement includes two of RemitDATA's SaaS-based RCM products:

  • Reimbursement PRO, a solution that provides reimbursement and utilization reports, analysis and tools for outpatient providers
  • WebScan PRO, a HIPAA-secure, EOB/Document management solution that significantly reduces document retrieval time through use of optical character recognition (OCR)-based technology. WebScan PRO identifies, indexes and files practice documents, such as EOBs, clinical notes and patient files, for immediate online use.

"There are three qualities that attracted us to SYNNEX," said Dave Ellett, chief executive officer of RemitDATA Inc. "SYNNEX has a dedicated healthcare solutions team, a solid strategy plan for the market and a complete outreach program that will help resellers understand the latest market information and assist them through the sales cycle."

RemitDATA is a leader in real-time, SaaS-based reimbursement and utilization solutions, providing transparent data, actionable insights, comparative analysis and digital document management to the outpatient healthcare provider market through channel partners. Currently, RemitDATA serves more than 75,000 healthcare providers throughout the United States.

Based in Memphis, Tennessee, and Dallas, Texas, the company has enjoyed a more than 90-percent client renewal rate since its inception in 2000.

For more information about RemitDATA products and services, please visit www.RemitDATA.com or call (866) 885-2974.

For more information about SYNNEX, please visit www.synnex.com.

Source:

RemitDATA Inc

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Analysis of Alzheimer's disease and related dementias uncovers disparities in Maryland's rural communities